During nuclear export, Gle1 (the nuclear-pore-associated mRNA export factor) activates the DEAD-box protein Dbp5 to remodel exported mRNA-protein complexes on the cytoplasmic face of the nuclear pore complex. In this issue, Bolger et al. (2008) now report additional roles for Gle1 in translation initiation and termination.
to targets regulated by translational repression, but additional improvements are needed, possibly resulting in the identification of new sequence and structure parameters for this target class.
The two reports (Baek et al., 2008; Selbach et al., 2008) have provided a wealth of data that will keep both experimental and computational biologists busy for some time to come. The wider application of these powerful new approaches to different experimental systems will help to address many of the questions that we have raised here. Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., and Rajewsky, N. (2008) . Nature, in press. Published online July 30, 2008 July 30, . 10.1038 Vinther, J., Hedegaard, M.M., Gardner, P.P., Andersen, J.S., and Arctander, P. (2006) . Nucleic Acids Res. 34, e107. Mammals have developed elaborate mechanisms to prevent disease and injury and to initiate healing responses should those prevention mechanisms fail. A good example of a disease-prevention mechanism is cellular senescence, a state in which cell division is permanently arrested (reviewed in Collado et al., 2007) . This phenomenon was originally discovered in cultured primary cells that stop proliferating after a finite number of divisions (replicative senescence). We now know that replicative senescence is due, at least in part, to erosion of telomeres, which occurs at each cell division. Senescent cells have a distinct phenotype that includes characteristic alterations in morphology, gene expression patterns, and chromatin structure. Specific genes are known to be required for senescence induction, thus revealing the existence of a defined genetic program. But why would cells develop a mechanism to permanently halt proliferation? Findings in experimental mouse cancer models and with human tumor samples hinted at the answer: precancerous tissues are composed of senescent cells (reviewed in Campisi, 2005; Sharpless and DePinho, 2005) . These observations led to the notion that induction of cellular senescence provides an intrinsic barrier to cancer development by preventing the proliferation of cells that are damaged or at risk for neoplastic transformation. In this issue, Krizhanovsky et al. (2008) add a new dimension to the cellular senescence story by demonstrating that senescence is also required in the normal response to injury in the liver.
In their original studies of the physiological response to liver damage in a mouse model, Krizhanovsky and colleagues, rather surprisingly, observed senescent cells in the liver. In their liver injury model, mice are treated with the chemical carbon tetrachloride to induce fibrosis, the primary response of the liver to injury. Fibrosis is a wound healing process characterized by the deposition of extracellular matrix components including collagens, proteoglycans, and fibronectins, which help to encapsulate the injury site (reviewed in Friedman, 2008) . Liver fibrosis is a precursor to cirrhosis, a significant health problem caused by diverse liver-damaging agents such as excessive alcohol, viral hepatitis, and toxins. Hepatic stellate cells (HSCs) are the primary modulators of liver fibrosis and are activated following damage to hepatocytes, the predominant cell type in liver tissue. Activated HSCs are characterized by increased proliferation and motility and, most importantly, by increased synthesis of extracellular matrix components. Krizhanovsky et al. Cellular senescence provides an intrinsic barrier to tumor development by preventing the proliferation of cells that are at risk for malignant transformation. In this issue, Krizhanovsky et al. (2008) report that senescence is an important player not only in tumor suppression but also in the response of liver tissue to injury.
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observed that within the fibrotic regions of carbon tetrachloride-treated mouse livers were cells that, based upon characteristic molecular markers, had undergone senescence. Although senescent cells had been detected in cirrhotic human liver in other studies, these cells were thought to be hepatocytes (Wiemann et al., 2002) . Krizhanovsky et al. characterized the senescent cells in fibrotic mouse livers and discovered that they were not hepatocytes but were HSCs, suggesting a possible link between cellular senescence and the response to tissue injury. It is well established that specific genes including the classic tumor suppressor genes p53 and Rb are required for senescence induction. When Krizhanovsky et al. induced liver fibrosis in mice lacking an intact p53 pathway (or lacking intact p53 and Rb pathways), they found that the amount of fibrosis was substantially increased. This increase in fibrosis was accompanied by an increased number of activated HSCs and, significantly, a decreased number of senescent HSCs. Taken together, these results led the authors to conclude that induction of senescence limits the number of activated HSCs and thus the progression of fibrosis.
The authors then showed that senescence also appears to play a role in the resolution of fibrosis. In both human patients and experimental mouse models, fibrosis can be reversed following elimination of the liver-damaging agent. Krizhanovsky et al. found that during resolution of fibrosis, the number of both activated and senescent HSCs decreased. However, in mice lacking an intact p53 (or p53 and Rb) pathway, fibrotic resolution was impaired and there was an increased number of activated HSCs compared to wild-type mice. Collectively, these observations suggest that senescence limits proliferation of activated HSCs, thereby promoting fibrotic resolution.
Intriguingly, the investigators observed that the senescent HSCs seem to do more than just stop proliferating. Expression profiling experiments revealed that when induced to undergo senescence, HSCs upregulate a set of genes encoding proteins that enhance immune surveillance. Indeed, immune modulatory cells including natural killer (NK) cells were found to accumulate in the fibrotic regions of the mouse liver. These observations led the authors to propose that the senescent HSCs are responsible for attracting immune modulatory cells to fibrotic areas. In previous work, these investigators had established that liver carcinoma cells induced to undergo senescence were cleared by NK cells, leading to tumor regression (Xue et al., 2007) . This finding prompted them to analyze the role of NK cells in eliminating senescent HSCs from fibrotic liver tissue. They found that mice depleted of NK cells by the addition of an NK cell-specific neutralizing antibody were unable to eliminate senescent HSCs or to resolve fibrosis. Thus, senescent HSCs not only permanently arrest their own growth but also orchestrate their own elimination by attracting NK cells.
The results of Krizhanovsky et al. suggest a model (Figure 1 ) in which a single cell type senses tissue damage and directs both the response to the damage and the subsequent resolution of the response. Upon liver damage, HSCs become activated and proliferate to mediate the fibrotic response to injury before eventually succumbing to senescence and clearance, in this way protecting the liver from excessive fibrogenesis. According to this model, senescence both limits the expansion of cells responsible for fibrosis and induces a gene expression program that signals clearance of the senescent cells.
As always, new findings raise new questions. Perhaps the most intriguing question is how senescence is initiated in activated HSCs. The authors provide a compelling argument that in the relatively short timeframe of HSC activation in their experimental mouse model, it is unlikely that the induction of senescence is due to excessive HSC replication. Moreover, mice have unusually long telomeres that provide a barrier to replicative senescence. One possible mechanism for HSC senescence is provided by an earlier study in which expression of an activated BRAF oncogene in primary melanocytes resulted in an initial proliferative burst followed by senescence induction (Michaloglou et al., 2005) . Krizhanovsky et al. speculate that as is the case with the BRAF-expressing melanocytes, some trigger such as Akt kinase signaling may induce an initial burst of HSC hyperproliferation. Indeed, the authors detected activated Akt in HSCs from fibrotic mouse liver and in senescent human HSCs in culture. Another important question pertains to how these new results can be reconciled with previous observations that HSCs undergo programmed cell death (apoptosis) during regression of liver fibrosis (reviewed in Elsharkawy et al., 2005) . One possibility is that apoptosis is an independent, secondary mechanism by which HSCs are cleared during fibrotic regression. Alternatively, HSC apoptosis In response to injury to liver hepatocytes, a second type of liver cell, the HSC (hepatic stellate cell), becomes activated. Increased proliferation of HSCs and their synthesis of extracellular matrix (ECM) components results in a wound healing response called fibrosis, which helps to contain the initial site of injury. After the initial damage response, activated HSCs then undergo senescence, thus limiting the amount of fibrosis. In addition, as they undergo senescence, HSCs attract natural killer (NK) cells to fibrotic areas, which results in the elimination of HSCs and the resolution of fibrosis.
may not be truly independent but rather an intrinsic part of the senescence pathway described by Krizhanovsky et al. Intriguingly, NK cells, which are attracted by the senescent HSCs, can induce apoptosis of many cell types including HSCs (Radaeva et al., 2006) . It remains to be seen whether this new model is specific to liver fibrosis or whether it represents a more general homeostatic mechanism involved in other wound healing responses. Regardless, this new study clearly demonstrates that the role of cellular senescence extends far beyond cancer prevention.
Mature cytoplasmic messenger RNAs (mRNAs) ready for translation are the products of a complex maturation pathway that starts concomitantly with transcription in the nucleus and includes nuclear pre-mRNA processing, mRNA export through nuclear pore complexes (NPCs), and remodeling of mRNA-ribonucleoprotein (mRNP) complexes in the cytoplasm. Recently, it has become clear that many of the consecutive events in this pathway are tightly interconnected, and the number of factors that influence multiple distinct steps in the mRNP biogenesis pathway is steadily increasing. New work by Bolger et al. (2008) in this issue now explores a fresh twist on the double duty carried out by proteins involved in mRNP biogenesis, in this case the role of the mRNA export factor Gle1 in translation initiation and termination.
Successful export of an mRNA first requires the association of the mRNA with proteins in the nucleus to form an export-competent mRNP. Recognition of this mRNP by the nuclear export receptor Mex67 (TAP/NXF1 in vertebrates) is then needed to facilitate mRNP translocation through NPCs. In addition, several other factors are necessary to ensure efficient mRNA export. Two such essential proteins are the mRNA export factor Gle1 and its partner Dbp5 (for review, see Cole and Scarcelli, 2006) . Dbp5 belongs to the family of DEAD-box-containing RNA helicases, which use the energy of ATP binding and hydrolysis to rearrange RNA structures or to dissociate proteins from RNA. Under steady-state conditions, a pool of both Dbp5 and Gle1 is strategically positioned on the cytoplasmic fibrils of the NPC to remodel mRNPs as soon as they emerge from the NPC channel. Elegant previous studies in the budding yeast Saccharomyces cerevisiae revealed that the low intrinsic, RNAdependent ATPase activity of Dbp5 is greatly stimulated by NPC-associated Gle1 and its soluble cofactor inositol hexakisphosphate (IP 6 ) (Alcazar-Roman et al., 2006; Weirich et al., 2006) . This control of Dbp5 activation by Gle1 (and IP 6 ), which is thought to be locally coupled to the NPC, is critical for efficient mRNA export. It is also involved in mRNP remodeling events such as the dissociation of the RNA-binding protein Nab2 (Tran et al., 2007) and the export receptor Mex67 (Lund and Guthrie, 2005) , which may contribute to the directionality of the mRNA export process.
In addition to the pools of Dbp5 and Gle1 attached to the NPC, both proteins are also found in the cytoplasm. Recent work in budding yeast has revealed a surprising cytoplasmic role for yeast Dbp5 in the termination of translation (Gross et al., 2007) . Translation termination occurs through recognition of a stop codon in the ribosomal A site by the polypeptide release factor eRF1, which together with eRF3 stimulates polypeptidyl-tRNA
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